Compare TWO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWO | ATRC |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | 486 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 2005 |
| Metric | TWO | ATRC |
|---|---|---|
| Price | $12.51 | $27.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $12.56 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 2.4M | 812.9K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 11.77% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | N/A | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $8.84 | $25.52 |
| 52 Week High | $14.17 | $43.18 |
| Indicator | TWO | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 65.80 | 44.76 |
| Support Level | $12.37 | $26.47 |
| Resistance Level | $12.70 | $30.49 |
| Average True Range (ATR) | 0.11 | 1.30 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 56.25 | 50.50 |
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, residential mortgage loans, mortgage servicing rights, and commercial real estate. The majority of its investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. The company derives revenues mainly from its MSR and Agency RMBS portfolio, including servicing fee income, float income, and interest income, as well as mortgage loan origination activities established to support the MSR portfolio. Its investment portfolio is subject to market risks, mainly interest rate, basis, and prepayment risk. The majority of income is generated by available-for-sale securities.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.